| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |